ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells.

Elizabeth A Lemm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.